Literature DB >> 36181621

A case of unresectable locally advanced intrahepatic cholangiocarcinoma that achieved pathological complete response after gemcitabine and S1 chemotherapy.

Tatsuaki Sumiyoshi1, Kenichiro Uemura2, Ryuta Shintakuya1, Kenjiro Okada1, Hiroyuki Otsuka1, Masahiro Serikawa3, Yasutaka Ishii3, Tomofumi Tsuboi3, Koji Arihiro4, Shinya Takahashi1.   

Abstract

The standard chemotherapy for patients with unresectable cholangiocarcinoma is gemcitabine plus cisplatin, and gemcitabine plus S-1 (GS) chemotherapy is also reported to have similar effectiveness in Japan. However, the response rates of these two chemotherapies were modest, and no patients with intrahepatic cholangiocarcinoma (ICC) have shown a pathological complete response (pCR) following these chemotherapies. We report here the first case of an initially unresectable locally advanced ICC that achieved pCR following GS chemotherapy.
© 2022. Japanese Society of Gastroenterology.

Entities:  

Keywords:  Gemcitabine; Intrahepatic cholangiocarcinoma; Pathological complete response; S-1

Year:  2022        PMID: 36181621     DOI: 10.1007/s12328-022-01700-x

Source DB:  PubMed          Journal:  Clin J Gastroenterol        ISSN: 1865-7265


  1 in total

1.  Complete Pathological Response to Neoadjuvant Chemoimmunotherapy in a Patient With Metastatic Intrahepatic Cholangiocarcinoma With High Tumor Mutational Burden.

Authors:  Mohammad Abudalou; Eduardo A Vega; Svetlana Kondratiev; Claudius Conrad; Olga Kozyreva
Journal:  Cureus       Date:  2021-12-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.